References
- Nicoloff JT, Spencer CA. Clinical review 12: the use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab 1990; 71(3):553–8
- Brown CA, Hennessey JV. Clinical significance of mildly elevated thyrotropin levels with normal thyroxine levels. South Med J 1989; 82(6):681–5
- Hamburger JI, Kaplan MM. Hypothyroidism: don't treat patients who don't have it. Postgrad Med 1989;86(l):67–74
- Helfand M, Crapo LM. Screening for thyroid disease. Ann Intern Med 1990;112(11): 840–9
- Sawin CT, Castelli WP, Hershman JM, et al. The aging thyroid: thyroid deficiency in the Framingham Study. Arch Intern Med 1985; l45(8):1386–8
- Bagchi N, Brown TR, Parish RF. Thyroid dysfunction in adults over age 55 years: a study in an urban US community. Arch Intern Med 1990;150(4):785–7
- Rosenthal MJ, Hunt WC, Garry PJ, et al. Thyroid failure in the elderly: microsomal antibodies as discriminant for therapy. JAMA 1987; 258(2):209–13
- Cooper DS, Halpern R, Wood LC, et al. L-Thyroxine therapy in subclinical hypothyroidism: a double-blind, placebo-controlled trial. Ann Intern Med 1984;101(l):18–24
- Nyström E, Caidahl K, Fager G, et al. A double-blind cross-over 12-month study of L-thyroxine treatment of women with ‘subclinical’ hypothyroidism. Clin Endocrinol (Oxf) 1988;29(l):63–75
- Staub JJ, Althaus BU, Engter H, et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. Am J Med 1992;92(6):631–42
- Klein I, Ojamaa K. Clinical review 36: cardiovascular manifestations of endocrine disease. J Clin Endocrinol Metab 1992;75(2): 339–42
- Bell GM, Todd WT, Forfar JC, et al. End-organ responses to thyroxine therapy in subclinical hypothyroidism. Clin Endocrinol (Oxf) 1985;22(l):83–9
- Forfar JC, Wathen CG, Todd WT, et al. Left ventricular performance in subclinical hypothyroidism. QJ Med 1985;57(224):857–65
- Glueck CJ, Lang J, Tracy T, et al. The common finding of covert hypothyroidism at initial clinical evaluation for hyperlipoproteinemia. Clin Chim Acta 1991;201(1–2):113–22
- Elder J, McLelland A, O'Reilly DS, et al. The relationship between serum cholesterol and serum thyrotropin, thyroxine and triiodothyronine concentrations in suspected hypothyroidism. Ann Clin Biochem 1990;27 (Pt 2):110–3
- Althaus BU, Staub JJ, Ryff-De Lèche A, et al. LDL/HDL-changes in subclinical hypothyroidism: possible risk factors for coronary heart disease. Clin Endocrinol (Oxf) 1988; 28(2): 157–63
- Caron P, Calazcl C, Parra HJ, et al. Decreased HDL cholesterol in subclinical hypothyroidism: the effect of L-thyroxine therapy. Clin Endocrinol (Oxf) 1990;33(4):519–23
- Arem R, Patsch W. Lipoprotein and apolipoprotein levels in subclinical hypothyroidism: effect of levothyroxine therapy. Arch Intern Med 1990;150(10):2097–100
- Paul TL, Kerrigan J, Kelly AM, et al. Long-term L-thyroxine therapy is associated with decreased hip bone density in premenopausal women. JAMA 1988;259(21):3137–41
- Stall GM, Harris S, Sokoll LJ, et al. Accelerated bone loss in hypothyroid patients overtreated with L-thyroxine. Ann Intern Med 1990;113(4):265–9
- Ross DS. Bone density is not reduced during short-term administration of levothyroxine to post-menopausal women with subclinical hypothyroidism: a randomized prospective study. Thyroid 1992;2(Aug):S-37